Jayesh Lifescience India Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 5.00 M
- Company Age 9 Year, 10 Months
- Last Filing with ROC 31 Mar 2018
- Open Charges ₹ 11.25 Cr
- Revenue Growth 95.00%
- Profit Growth 106.29%
- Ebitda 174.75%
- Net Worth 12.04%
- Total Assets 21.13%
About Jayesh Lifescience India
Company Details
-
Location
Thane, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U74999MH2015PTC263269
-
Company No.
263269
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
01 Apr 2015
-
Date of AGM
29 Sep 2018
-
Date of Balance Sheet
31 Mar 2018
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Jayesh Lifescience India?
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Dinesh Prajapati
![]() |
Director | 22-Jan-2018 | Current |
Singheshwar Thakur
![]() |
Director | 22-Jan-2018 | Current |
Financial Performance of Jayesh Lifescience India.
Jayesh Lifescience India Private Limited, for the financial year ended 2018, experienced significant growth in revenue, with a 95% increase. The company also saw a substantial improvement in profitability, with a 106.29% increase in profit. The company's net worth Soared by an impressive increase of 12.04%.
![Graph illustrating revenue growth over time](/Images/financial/revenue-growth.webp)
![Graph showing profit and loss trends over time](/Images/financial/profit-loss.webp)
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Jayesh Lifescience India?
In 2018, Jayesh Lifescience India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
![Shareholding Indicator graph](/Images/tcc-login/Shareholding-Indiacator-1200.webp)
Charges (Loans)
₹112.50 M
₹0
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 7.50 Cr
- State Bank Of India : 3.75 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
30 Mar 2019 | State Bank Of India | ₹3.75 Cr | Open |
30 Sep 2016 | Axis Bank Limited | ₹7.50 Cr | Open |
How Many Employees Work at Jayesh Lifescience India?
Unlock and access historical data on people associated with Jayesh Lifescience India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
![Graph showing employee growth trends](/Images/tcc-login/Employee-Graph.webp)
Deals i
![Graph showing company valuation over time](/Images/tcc-login/Valuation-Graph-small.webp)
Gain comprehensive insights into the Deals and Valuation data of Jayesh Lifescience India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jayesh Lifescience India's trajectory.
Rating
![Graph displaying rating trends over time](/Images/tcc-login/Rating-Graph-small.webp)
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
![Alert Indicator](/Images/tcc-login/Alert-Indicator-small.webp)
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.